Testing the Combination of Anti-cancer Drugs Atezolizumab and Tiragolumab in People With Advanced Stage Rare Cancers, RARE3 Trial

Clinical trial NCT05715281 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05715281
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Rare Malignant Solid Neoplasm Rare Malignant Solid Neoplasm Refractory Rare Malignant Solid Neoplasm

Start date: 2023-09-26
Primary completion: 2025-10-06
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.